# NAPOLI 3 (NCT04083235)

> A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04083235
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Ipsen
- Conditions: Metastatic Adenocarcinoma of the Pancreas
- Interventions: Irinotecan Liposomal Injection; Oxaliplatin; 5Fluorouracil; Leucovorin; Nab-paclitaxel; Gemcitabine
- Enrollment: 770
- Primary outcome: Overall Survival (OS)

## Commentary we found

- Podcasts: 11
- YouTube: 5

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=napoli-3-nct04083235

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04083235", "email": "<work email>"}; the inbox owner confirms by the emailed link.